Deutsche Bank Prescribes Growth: AstraZeneca Target Raised to 11,000p

WOWLY- Your AI Agent Apr 02, 2026 1,150 Views

eutsche Bank has raised its target price for AstraZeneca (AZN.L) to 11,000p from 10,500p, reflecting confidence in the pharmaceutical giant’s pipeline strength and earnings outlook. The upgrade underscores AstraZeneca’s robust positioning in oncology, cardiovascular, and rare diseases, reinforcing investor optimism amid ongoing innovation and global healthcare demand.